title: Hyperprogressive disease with anti-PD-1 and anti-PD-L1.
authors.forename: Vicki
authors.initials: V
authors.lastname: Brower
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors* / Q000276:immunology; D017321:Clinical Trials, Phase I as Topic; D018450:Disease Progression; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000473:pathology; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors* / Q000276:immunology; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000074322:Antineoplastic Agents, Immunological; D060890:B7-H1 Antigen; C423236:CD274 protein, human; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor